kras mutation and glutathion glynac The Role of Mutations in Colorectal Cancer: Biological Insights, Clinical Implications, Future Therapeutic Perspectives The Metabolic Landscape of RAS-Driven
The Metabolic Landscape of RAS Driven Cancers from biology to therapy PMC What should we know about the 'undruggable' target KRAS? MedChemExpress Metabolic reprogramming in KRAS mutant cancers: Proven targetable vulnerabilities and potential therapeutic strategies ScienceDirect Glutathione Depletion and Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Cancer Therapy ACS Omega Pancreatic Cancer: Advances and Challenges PMC KRAS OriGene Technologies Inc.
Pay in 4 interest-free payments of $6.47 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1





